Page 15 - Immunizations News Today

Pfizer and BioNTech said an early trial of a combined Covid-19 and influenza vaccine had produced positive data. The companies are set for a race with...

Pfizer, Moderna and Novavax believe combination shots will simplify the process for people to protect themselves against Covid and the flu.

Bavarian Nordic said on Wednesday a CDC panel has voted in favor of recommending the routine use of Jynneos vaccine for adults at risk of mpox.

COVID-19 increases the risk for Guillain-Barré syndrome sixfold, while getting the Pfizer mRNA vaccine lowers risk.

The results suggest that GSK's shot could help protect a wider population from RSV, which causes thousands of hospitalizations and deaths each year.

The U.K. drugmaker GSK is seeking to expand regulatory approval for its new respiratory syncytial virus vaccine to include younger adults.

Moderna Inc. investors enjoyed a rare rally Tuesday as the shares of the biotechnology company headed for their first gain in two weeks.

By Josh Beckerman Moderna said the first participant has been dosed in a Phase 3 study of mRNA-1083, its combination vaccine candidate against influenza and...

Dozens of individuals referenced in a book co-published by RFK Jr.'s Children's Health Defense died of known causes not related to vaccines, including...

The single shot will cover the five most common serogroups that cause meningococcal disease in children and young adults.